OZEM
Roundhill Glp-1 & Weight Loss ETF
Set alert
30.70 USD +0.41 +1.35%
30.56 Day range 30.86
28.14 52-week range 37.01
- YTD
- -10.14%
- 1 year
- +9.08%
- Open
- 30.75
- Prev close
- 30.29
- Mkt cap
- 39.00M
- Vol
- 20.54K
- Avg vol
- 15.25K
- EPS
- 1.66
- P/E
- 18.46
- Div yield
- 0.00%
More statistics
- Low
- 30.56
- High
- 30.86
- Forward P/E
- 0.00
- Beta
- 0.00
- Short ratio
- 0.00
- Dividend
- 0.00
- Ex-div date
- 50-d avg
- 26.99
- 200-d avg
- 27.14
Key statistics
- Market cap
- 0
- Enterprise value
- 0
- Trailing P/E
- 27.66
- Forward P/E
- 0.00
- PEG ratio
- 0.00
- Price / sales
- 0.00
- Price / book
- 0.00
- EPS (TTM)
- 0.00
- Beta
- 0.00
- Dividend yield
- 0.00%
- Payout ratio
- 0.00%
- Shares outstanding
- 0
- Short % of float
- 0.00%
- 50-day average
- 26.99
- 200-day average
- 27.14
About Roundhill Glp-1 & Weight Loss ETF
The fund's manager will invest at least 80% of its net assets (plus any borrowings for investment purposes) in the equity securities of GLP-1 & Weight Loss Companies or any derivative instruments (such as swap agreements or forward contracts) that utilize one or more GLP-1 & Weight Loss Companies as the reference asset. The fund is non-diversified.
News
- Obesity ETFs to Gain as Novo's CagriSema Shows 25% Weight Loss
- Bet on This New GLP-1 ETF to Gain Exposure to a Booming Market
- Roundhill GLP-1 & Weight Loss ETF (NASDAQ:OZEM) Stock Price Down 0.6% – Time to Sell?
- From Laggard to Leader: The Surprising Comeback of Healthcare
- Lilly vs. Novo: Inside the Milan EASD Showdown and the ETFs Poised to Win
- Roundhill GLP-1 & Weight Loss ETF (NASDAQ:OZEM) Shares Down 0.4% – Time to Sell?
- Weight Loss ETFs Poised to Rally as Medicare Greenlights GLP-1 Coverage
- Healthcare ETFs: From Broad Exposure to Big Breakthroughs
- Inside the GLP-1 Boom: ETF Picks for the Obesity Drug Market
- GLP-1 Drug Giants Race to Go Global With Their Obesity Pills: ETFs to Gain
Your note
Sign in to keep a note on OZEM — it syncs with the Stock Master app.